Top Markets
Coin of the day
Graybug Vision, Inc. Graybug Vision, Inc.

Graybug Vision, Inc.

GRAY
Rangering i aksjer #35305
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical... Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.
Aksjekurs
$2.70
Sist synkronisert: 2023-05-17
Markedsverdi
$4.13M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Graybug Vision, Inc. (GRAY)

Kategori

Historikk for aksjesplitt for Graybug Vision, Inc. (GRAY)
Aksjen Graybug Vision, Inc. (symbol: GRAY) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 16, 2026.
Én GRAY-aksje kjøpt før Aug 16, 2026 tilsvarer i dag 0 GRAY-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE